These findings strongly suggest that IP3R-1 plays a significant role in the development and progression of skin cancer, with its altered expression observed early in carcinogenesis. Nevertheless, its expression does not correlate with typical clinical-pathological aspects of neoplasia.
Gruber et al. (Tue,) studied this question.